Overview of the 8th Edition TNM Classification for Head and Neck Cancer
Top Cited Papers
- 29 May 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Treatment Options in Oncology
- Vol. 18 (7), 40
- https://doi.org/10.1007/s11864-017-0484-y
Abstract
The main purpose of the TNM system is to provide an anatomic-based classification to adequately depict cancer prognosis. Accurate cancer staging is important for treatment selection and outcome prediction, research design, and cancer control activities. To maintain clinical relevance, periodical updates to TNM are necessary. The recently published 8th edition TNM classification institutes the following changes to the staging of head and neck (excluding thyroid cancer): new stage classifications [HPV-related oropharyngeal cancer (HPV+ OPC) and soft tissue sarcoma of the head and neck (HN-STS)] and modification of T and N categories [T and N categories for nasopharyngeal cancer (NPC), T categories for oral cavity squamous cell carcinomas (OSCC), N categories for non-viral related head and neck cancer and unknown primary (CUP), and T categories for head and neck cutaneous carcinoma]. These changes reflect better understanding tumor biology and clinical behavior (e.g., HPV+ OPC and HN-STS), improved outcomes associated with technical advances in diagnosis and treatment (e.g., NPC), evolving knowledge about additional prognostic factors and risk stratification from research and observation (e.g., inclusion of depth of invasion variable for OSCC, inclusion of extranodal extension variable for all non-viral head and neck cancer, and reintroduction of size criteria for non-Merkel cell cutaneous carcinoma of the head and neck). This review summarizes the changes and potential advantages and limitations/caveats associated with them. Further evidence is needed to evaluate whether these changes would result in improvement in TNM stage performance to better serve the needs for clinical care, research, and cancer control.Keywords
This publication has 53 references indexed in Scilit:
- Correlation between nasopharyngeal carcinoma tumor volume and the 2002 International Union Against Cancer tumor classification systemRadiation Oncology, 2013
- Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus–associated head and neck squamous cell carcinoma?Annals of Diagnostic Pathology, 2011
- p16 expression as a surrogate marker for HPV‐related oropharyngeal carcinoma: A guide for interpretative relevance and consistencyHead & Neck, 2011
- Extracapsular spread and adjuvant therapy in human papillomavirus‐related, p16‐positive oropharyngeal carcinomaCancer, 2011
- Human papillomavirus reduces the prognostic value of nodal involvement in tonsillar squamous cell carcinomasThe Laryngoscope, 2009
- Predictive value of tumor thickness for cervical lymph‐node involvement in squamous cell carcinoma of the oral cavityCancer, 2009
- Mortality Risk From Squamous Cell Skin CancerJournal of Clinical Oncology, 2005
- The process for continuous improvement of the TNM classificationCancer, 2003
- Pretherapy quantitative measurement of circulating Epstein–Barr virus DNA is predictive of posttherapy distant failure in patients with early‐stage nasopharyngeal carcinoma of undifferentiated typeCancer, 2003
- Tumor thickness influences prognosis of T1 and T2 oral cavity cancer—but what thickness?Head & Neck, 2003